Elanco Animal Health (ELAN) Restructuring Costs (2017 - 2026)
Elanco Animal Health's (ELAN) quarterly Restructuring Costs came in at $9.0 million in Q2 2026, up 800.0% year-over-year from $1.0 million in Q2 2025, and down 43.75% quarter-over-quarter from $16.0 million in Q1 2026.
Analysis
Elanco Animal Health (ELAN) Restructuring Costs (2017 - 2026) Analysis & Trends
Elanco Animal Health has disclosed Restructuring Costs across 10 years of filings, most recently posting $9.0 million for Q2 2026.
- In Q2 2026, Restructuring Costs rose 800.0% year-over-year to $9.0 million; the TTM figure through Jun 2026 stood at $252.0 million (up 641.18% YoY), while the FY2025 annual figure was $237.0 million, up 58.0% from the prior year.
- Restructuring Costs came in at $9.0 million for Q2 2026 at Elanco Animal Health, down from $16.0 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $202.0 million in Q4 2025 to a low of $1.0 million in Q2 2025.
- Average Restructuring Costs over 5 years is $40.1 million, with a median of $28.5 million recorded in 2022.
- The largest YoY upside for Restructuring Costs was 2785.71% in 2025 against a maximum downside of 98.75% in 2025.
- Over 5 years, Restructuring Costs stood at $31.0 million in 2022, then gained by 16.13% to $36.0 million in 2023, then plunged by 80.56% to $7.0 million in 2024, then surged by 2785.71% to $202.0 million in 2025, then plunged by 95.54% to $9.0 million in 2026.
- Per Business Quant data, the three most recent Restructuring Costs figures were $9.0 million in Q2 2026, $16.0 million in Q1 2026, and $202.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.55 Bn | 40.36 Bn | 779.09 Mn |
| 2 | Zoetis | 30.68 Bn | 29.00 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 75.05 Mn | 67.96 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.00 Mn |
| Mar 31, 2026 | 16.00 Mn |
| Dec 31, 2025 | 202.00 Mn |
| Sep 30, 2025 | 25.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Sep 30, 2024 | 17.00 Mn |
| Jun 30, 2024 | 80.00 Mn |
| Mar 31, 2024 | 46.00 Mn |
| Dec 31, 2023 | 36.00 Mn |
| Sep 30, 2023 | 16.00 Mn |
| Jun 30, 2023 | 35.00 Mn |
| Mar 31, 2023 | 40.00 Mn |
| Dec 31, 2022 | 31.00 Mn |
| Sep 30, 2022 | 26.00 Mn |
| Jun 30, 2022 | 86.00 Mn |
| Mar 31, 2022 | 40.00 Mn |
| Dec 31, 2021 | 116.00 Mn |
| Sep 30, 2021 | 111.00 Mn |